These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 18472964)

  • 1. Decitabine-induced demethylation of 5' CpG island in GADD45A leads to apoptosis in osteosarcoma cells.
    Al-Romaih K; Sadikovic B; Yoshimoto M; Wang Y; Zielenska M; Squire JA
    Neoplasia; 2008 May; 10(5):471-80. PubMed ID: 18472964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fas expression in metastatic osteosarcoma cells is not regulated by CpG island methylation.
    Huang G; Koshkina NV; Kleinerman ES
    Oncol Res; 2009; 18(1):31-9. PubMed ID: 19911702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation by decitabine of gene expression and growth of osteosarcoma U2OS cells in vitro and in xenografts: identification of apoptotic genes as targets for demethylation.
    Al-Romaih K; Somers GR; Bayani J; Hughes S; Prasad M; Cutz JC; Xue H; Zielenska M; Wang Y; Squire JA
    Cancer Cell Int; 2007 Sep; 7():14. PubMed ID: 17845729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of the WNT5A Alternative Promoter B Is Associated with DNA Methylation and Histone Modification in Osteosarcoma Cell Lines U2OS and SaOS-2.
    Vaidya H; Rumph C; Katula KS
    PLoS One; 2016; 11(3):e0151392. PubMed ID: 26978652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of dna methylation by 5-aza-2'-deoxycytidine correlates with induction of K562 cells differentiation.
    Fabianowska-Majewska K; Wyczechowska D; Czyz M
    Adv Exp Med Biol; 2000; 486():343-7. PubMed ID: 11783512
    [No Abstract]   [Full Text] [Related]  

  • 6. The stress-responsive gene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumors.
    Ying J; Srivastava G; Hsieh WS; Gao Z; Murray P; Liao SK; Ambinder R; Tao Q
    Clin Cancer Res; 2005 Sep; 11(18):6442-9. PubMed ID: 16166418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-azacytidine and decitabine exert proapoptotic effects on neoplastic mast cells: role of FAS-demethylation and FAS re-expression, and synergism with FAS-ligand.
    Ghanim V; Herrmann H; Heller G; Peter B; Hadzijusufovic E; Blatt K; Schuch K; Cerny-Reiterer S; Mirkina I; Karlic H; Pickl WF; Zöchbauer-Müller S; Valent P
    Blood; 2012 May; 119(18):4242-52. PubMed ID: 22438247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GADD45 deregulation in cancer: frequently methylated tumor suppressors and potential therapeutic targets.
    Zerbini LF; Libermann TA
    Clin Cancer Res; 2005 Sep; 11(18):6409-13. PubMed ID: 16166414
    [No Abstract]   [Full Text] [Related]  

  • 9. Sequential decitabine and carboplatin treatment increases the DNA repair protein XPC, increases apoptosis and decreases proliferation in melanoma.
    Budden T; van der Westhuizen A; Bowden NA
    BMC Cancer; 2018 Jan; 18(1):100. PubMed ID: 29373959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation-mediated regulation of the glutathione S-transferase P1 gene in human breast cancer cells.
    Jhaveri MS; Morrow CS
    Gene; 1998 Mar; 210(1):1-7. PubMed ID: 9524203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I and pharmacodynamic trial of the DNA methyltransferase inhibitor decitabine and carboplatin in solid tumors.
    Appleton K; Mackay HJ; Judson I; Plumb JA; McCormick C; Strathdee G; Lee C; Barrett S; Reade S; Jadayel D; Tang A; Bellenger K; Mackay L; Setanoians A; Schätzlein A; Twelves C; Kaye SB; Brown R
    J Clin Oncol; 2007 Oct; 25(29):4603-9. PubMed ID: 17925555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azacytidine and decitabine induce gene-specific and non-random DNA demethylation in human cancer cell lines.
    Hagemann S; Heil O; Lyko F; Brueckner B
    PLoS One; 2011 Mar; 6(3):e17388. PubMed ID: 21408221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies.
    Katzenellenbogen RA; Baylin SB; Herman JG
    Blood; 1999 Jun; 93(12):4347-53. PubMed ID: 10361133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transformation-dependent silencing of tumor-selective apoptosis-inducing TRAIL by DNA hypermethylation is antagonized by decitabine.
    Lund P; Kotova I; Kedinger V; Khanwalkar H; Voltz E; Hahn WC; Gronemeyer H
    Mol Cancer Ther; 2011 Sep; 10(9):1611-23. PubMed ID: 21697397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative analysis of DNA demethylation and transcriptional reactivation of the FMR1 gene in fragile X cells treated with 5-azadeoxycytidine.
    Pietrobono R; Pomponi MG; Tabolacci E; Oostra B; Chiurazzi P; Neri G
    Nucleic Acids Res; 2002 Jul; 30(14):3278-85. PubMed ID: 12136110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53-inducible ribonucleotide reductase (p53R2/RRM2B) is a DNA hypomethylation-independent decitabine gene target that correlates with clinical response in myelodysplastic syndrome/acute myelogenous leukemia.
    Link PA; Baer MR; James SR; Jones DA; Karpf AR
    Cancer Res; 2008 Nov; 68(22):9358-66. PubMed ID: 19010910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of methylation-sensitive transcriptome identifies GADD45a as a frequently methylated gene in breast cancer.
    Wang W; Huper G; Guo Y; Murphy SK; Olson JA; Marks JR
    Oncogene; 2005 Apr; 24(16):2705-14. PubMed ID: 15735726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of Cdc6 inhibits tumorigenesis of osteosarcoma in vivo and in vitro.
    Jiang W; Yu Y; Liu J; Zhao Q; Wang J; Zhang J; Dang X
    Biomed Pharmacother; 2019 Jul; 115():108949. PubMed ID: 31100539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crucial role of DNA methylation in determination of clonally distributed killer cell Ig-like receptor expression patterns in NK cells.
    Santourlidis S; Trompeter HI; Weinhold S; Eisermann B; Meyer KL; Wernet P; Uhrberg M
    J Immunol; 2002 Oct; 169(8):4253-61. PubMed ID: 12370356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation profiles of thirty four promoter-CpG islands and concordant methylation behaviours of sixteen genes that may contribute to carcinogenesis of astrocytoma.
    Yu J; Zhang H; Gu J; Lin S; Li J; Lu W; Wang Y; Zhu J
    BMC Cancer; 2004 Sep; 4():65. PubMed ID: 15367334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.